BioCentury
ARTICLE | Clinical News

Maintate bisoprolol fumarate regulatory update

September 24, 2012 7:00 AM UTC

Mitsubishi submitted a regulatory application in Japan to expand the label of Maintate bisoprolol fumarate tablets to include treatment of chronic atrial fibrillation. The selective adrenergic recept...